NAP-AX-26-001: Leading Edge Acceleration Projects (LEAP) in Health Information Technology
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Office of the National Coordinator notices from 2026.
Office of the National Coordinator offered grants of up to $1.0 million (at least $500,000) to nonprofits, colleges and universities, state and local governments and tribes. It expected to make about 3 awards. Applications closed on July 16, 2026.
From the official notice on Grants.gov, last changed June 16, 2026. Checked November 7, 2026.
- Award ceiling$1.0 million
- Award floor$500,000
- Expected awards3
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | June 16, 2026 |
|---|---|
| Deadline | July 16, 2026 |
| Archived by Grants.gov | August 15, 2026 |
Who can apply
This opportunity was open to nonprofits, colleges and universities, state and local governments and tribes.
All 6 applicant types the notice lists
- State governments
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
For-profit organizations may participate in projects as members of a consortia or as a sub-recipient only. Because the purpose of this NOFO is to improve health care in the United States, foreign institutions may participate in projects as members of a consortia or as a sub-recipient only. Applications submitted by for-profit organizations or foreign institutions will not be reviewed. Organizations described in section 501(c)4 of the Internal Revenue Code that engage in lobbying activities are not eligible.
Is this a realistic fit?
- Past Leading Edge Acceleration Projects (LEAP) in Health Information Technology awards averaged $893,853; this notice allows up to $1.0 million per award.
- Most of the program's money (70% over five years) went to nonprofits.
- No cost sharing or match is required.
What the grant funds
While working to implement Cures Act provisions, ONC identified gaps with respect to leveraging EHR data to support population-level analyses and delivery of services, as well as integrating clinical knowledge into routine clinical practice. The reasons for these gaps range from a lack of data standards and interoperability to the digitization, integration, and presentation of new evidence into clinical workflows in safe, useful, and useable ways. Therefore, this funding opportunity will support innovative and breakthrough solutions critical to maximize the potential of health IT and achieve the goal of a transformed health care delivery system through various methods, such as:• Determining the fundamental questions, the answers to which will identify barriers to nationwide interoperability and electronic exchange of health data.• Engaging the health IT industry, along with academic researchers, to identify and develop innovative solutions that address barriers to interoperability.• Disseminating findings from research while fostering collaboration, advancement, and implementation of solutions and lessons learned with the health IT industry.
Who has won Leading Edge Acceleration Projects (LEAP) in Health Information Technology grants before
From fiscal 2021 to 2025, Leading Edge Acceleration Projects (LEAP) in Health Information Technology (93.345) awarded $9.8 million across 11 grant awards, an average of $893,853 per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| The Children's Hospital Corporation | Massachusetts | 2 | $1.0 million |
| Alliancechicago | Illinois | 1 | $1.0 million |
| Healthelink, Inc. | New York | 1 | $1.0 million |
| Dartnet Institute | Colorado | 1 | $999,990 |
| Healthcare Information and Management Systems Society | Illinois | 1 | $999,768 |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is NAP-AX-26-001 still open?
No. It closed on July 16, 2026.
Who can apply for Leading Edge Acceleration Projects (LEAP) in Health Information Technology?
Office of the National Coordinator accepted applications from nonprofits, colleges and universities, state and local governments and tribes. The notice adds further conditions, so read its eligibility section.
What is the deadline for Leading Edge Acceleration Projects (LEAP) in Health Information Technology?
Closed July 16, 2026. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $1.0 million each.
Who has won Leading Edge Acceleration Projects (LEAP) in Health Information Technology grants before?
The largest recipients over five fiscal years were The Children's Hospital Corporation, Alliancechicago, Healthelink, Inc. The program made 11 awards worth $9.8 million in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)